Cheryl Schwartz is the Senior Vice President of Fertility and Endocrinology at EMD Serono.
In this role, she oversees the strategic direction of the Fertility, Fertility Technologies and Endocrinology businesses in the U.S.
Before joining EMD Serono, Cheryl held positions of increasing responsibility at Pfizer, Inc., where she most recently served as General Manager of the U.S. Biosimilars business. In this role, she led Pfizer’s efforts to successfully commercialize a broad portfolio of assets for the emerging U.S. Biosimilars market.
Previously, Cheryl served as Vice President and Global Commercial Lead in Pfizer Vaccines, and held a range of other U.S. and Global commercial leadership roles spanning product lifecycles and therapeutic areas. Prior to joining Pfizer, her health care industry experience included roles at Forest Laboratories and Oxford Health Plans.
Cheryl holds an MBA from the Kellogg School of Management at Northwestern University and a bachelor’s degree from the University of Michigan-Ann Arbor.
You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.
If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website.